Please log in to view this page
Username
Password
The purpose of this study is to determine whether one or two four-month regimens of tuberculosis treatment are as effective as a...
HPTN 069 is a phase II, four-arm, multisite, randomized, double-blinded trial. To assess the safety and tolerability of four...
HPTN 083 is a study being done to evaluate the efficacy of the long-acting injectable agent, cabotegravir (CAB LA), for...
A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...
This study will enroll HIV-infected people who do not have evidence of active TB but who are at high risk of developing active...
